Healthcare IT & Genomics

Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, clinical trials/drug discovery and oncology informatics & diagnostics

Reports

Teleradiology - World - 2021

This is a proposal for a new Market Report on the global market for Teleradiology, to be published in April 2021.

Find out more

Signify Premium Insights – Medical Imaging - 2021

Subscribers to Signify Premium Insights – Medical Imaging receive approximately 100 actionable and up to the moment Premium Insights per year.

Find out more

High-Acuity and Perinatal IT - World - 2021

This is a proposal for a new Market Report on the global market for High-Acuity Care and Perinatal IT. The report examines the market for ICUIS, OR Manager, EDIS, Perinatal IT and AIMS.

Find out more

Digital Pathology – World – 2020

This report provides a detailed, data-centric analysis of the market for Digital Pathology. Features include global and country-level market estimates and forecasts for 2017-2024.

Find out more

Oncology IT - World - 2021

This is a proposal for Signify Research’s 2020 report on the global market for oncology IT to be published in May 2021.

Find out more

AI in Drug Development & Clinical Trials - World - 2020

This is a brochure for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials published in November 2020.

Find out more

Analyst Insights

Signify Premium Insight: The Options for Watson

Signify Premium Insights Subscription Required

March 2nd 2021 – IBM, and its plan to use AI to solve some of the biggest problems in healthcare, made headlines when it first announced its Watson Health division. Now however, the company is reportedly looking to sell the unit. This insight considers what’s changed to assess the rumours.

Signify Premium Insight: Intelerad Acquires LumedX – Now the Work Begins

Signify Premium Insights Subscription Required

February 25th 2021 – News broke last week that imaging IT vendor Intelerad has acquired LumedX, the latest in a rapid-fire acquisition streak from the imaging IT vendor, In this Insight we analyse the implications of the acquisition for the firms and postulate to the drivers and market context that have led to the deal.

Are EMR-based Oncology Modules Threatening Best-of-Breed Oncology IT?

18th February 2021 – With several EMR vendors now marketing their own Oncology-specific modules, healthcare providers will be deciding between best-of-breed and EMR-based offerings; so how this will affect the existing Oncology Information System (OIS) market, and how will incumbent vendors respond to the challenge?

Signify Premium Insight: Volpara Acquires CRA Health in $22m Deal

Signify Premium Insights Subscription Required

11th February 2021 – Breast health company Volpara has revealed it has acquired breast cancer risk assessment company, CRA Health in a deal worth $22m. In this Insight, we explore the motivations and potential impacts of the deal.

Signify Premium Insight: COVID-19’s Impact on the Imaging IT Market

Signify Premium Insights Subscription Required

9th February 2021 – The imaging IT market has not been immune to the impact of the COVID-19 pandemic. This insight explains how the market has been affected, as well as how vendors can best react to the changing conditions.